Roadshow
Electrocardiogram (ECG) Artificial Intelligence Analysis System
Our team's electrocardiogram (ECG) artificial intelligence analysis system, based on over one million data points and deep learning technology, can diagnose more than 50 cardiovascular diseases, with accuracy reaching the level of cardiac specialists.
Compared to traditional analysis, it is more precise and capable of diagnosing diseases that human experts cannot handle. This system maximizes the utility of ECG, assisting hospitals in acute diagnosis, providing inexpensive chronic screening, and enabling home monitoring. We have validated its improvement in medical care quality through randomized controlled trials and have transferred the technology to Quanta Group. It is expected to be submitted for TFDA review in Q3 of this year, certified by Q2 of next year, and will create new medical products in the future.
- Established 2019
- Company AIoT Center of the Tri-Service General Hospital
- Telephone +886-2-8792-3100
AIoT Center of the Tri-Service General Hospital was founded in 2019, focusing on the development of AI-based screening tools. Through deep learning, we have expanded the applications of electrocardiograms (ECG), not only diagnosing heart diseases but also estimating heart age and detecting heart failure, among other things. By transforming the medical system and acquiring rich annotated data for associative exploration, we refine essential and accurate items. After clinical trial verification, we promote them to various fields. Leveraging our institution's advantage in ECG data, our AI system has become a leading cardiovascular screening tool, applicable to medical institutions, emergency medical services, rural healthcare, self-funded health checks, and home care, all aimed at improving the quality of healthcare.